Status
Conditions
Treatments
About
The objectives of this study are to determine the effects of isoprinosine in patients diagnosed as having unexplained generalized lymphadenopathy. Variables to be examined will include:
Signs and symptoms:
Cell-mediated immune system parameters:
Safety parameters:
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Exclusion Criteria
Co-existing Condition:
Patients with a history of gout, uric acid urolithiasis, uric acid nephrolithiasis, renal dysfunction, or gastric ulceration are excluded.
Concurrent Medication:
Excluded:
Critically ill patients or those with CDC-defined AIDS are excluded.
Prior Medication:
Excluded within 1 month of study entry:
Patients with persistent generalized lymphadenopathy (PGL).
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal